- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 295/185 - Radicals derived from carboxylic acids from aliphatic carboxylic acids
Patent holdings for IPC class C07D 295/185
Total number of patents in this class: 474
10-year publication summary
40
|
47
|
39
|
45
|
30
|
29
|
43
|
28
|
24
|
10
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
F. Hoffmann-La Roche AG | 7958 |
8 |
The Regents of the University of California | 18943 |
8 |
Board of Regents, The University of Texas System | 5370 |
7 |
Modernatx, Inc. | 1181 |
7 |
Boehringer Ingelheim International GmbH | 4629 |
6 |
Rutgers, The State University of New Jersey | 1776 |
6 |
The Scripps Research Institute | 1364 |
6 |
Centre National de La Recherche Scientifique | 9632 |
5 |
President and Fellows of Harvard College | 5792 |
5 |
Dongguk University Industry-Academic Cooperation Foundation | 391 |
5 |
Emory University | 1498 |
5 |
Korea University Research and Business Foundation | 2561 |
5 |
PTC Therapeutics, Inc. | 492 |
5 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
5 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
5 |
Guangzhou Innocare Pharma Tech Co., Ltd. | 11 |
5 |
Novartis AG | 11238 |
4 |
Conopco, Inc. | 4644 |
4 |
Genentech, Inc. | 3742 |
4 |
Abbvie Inc. | 1808 |
4 |
Other owners | 365 |